PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

BGI Genomics partners with Zentya to launch fecal DNA test for colorectal cancer in Slovakia

BGI Genomics is pleased to announce the launch of COLOTECT™ 1.0 in Slovakia, in collaboration with its local partner, Zentya

BGI Genomics partners with Zentya to launch fecal DNA test for colorectal cancer in Slovakia
2023-03-30
(Press-News.org)

Bratislava, Slovakia, March 21, 2023

BGI Genomics is pleased to announce the launch of COLOTECTTM 1.0 in Slovakia, in collaboration with its local partner, Zentya. Zentya is a Slovak-based healthcare solution provider that is passionate about providing patients with the latest technology in the field of genetic screening, aiming to help identify and facilitate timely treatments of genetic diseases.

COLOTECTTM 1.0 is one of the first-ever fecal DNA tests for colorectal cancer that is available in the country. It is a non-invasive fecal DNA test developed by BGI Genomics for detecting colorectal cancer and precancerous lesions. It uses multiplex methylation-specific PCR (MSP) technology to trace abnormal colorectal cancer DNA-methylation biomarkers from fecal samples.

A product launch press conference was held by Zentya in Bratislava, Slovakia, on March 21, 2023. Dr. Martin Huroka (Chief Gastroenterology Specialist, Ministry of Health), Dr. Lucia Starovecká Copák (Medical Geneticist), and Dr. Jozef Dolinský (Clinical Oncologist), were the invited speakers of the event.

According to the World Cancer Research Fund Organization (2020), Slovakia has the second-highest colorectal cancer incidence rate worldwide and ranks the top in colorectal cancer mortality. This shows the urgency of promoting and encouraging colorectal cancer screening across the country.

Dr. Martin Huroka explained that age and family history of colon cancer are significant factors in the incidence of colorectal cancer. “The risk of colorectal cancer increases dramatically after age 50, or with a positive family history. Colorectal cancer is almost 100% preventable, and people would not have to die from intestinal cancer with regular preventive examinations”, Dr. Huroka stated.

Early detection is the key to the prevention of colorectal cancer and the improvement of survival rate because the progression of colorectal cancer development is generally very slow. It can take up to 10 to 15 years to develop from normal epithelium to adenomatous polyps and then undergo malignant transformation to become colorectal cancer.

“The slow development of the disease creates a favorable opportunity for its early detection and intervention -- timely removal of adenomatous polyps. When diagnosed early - localized stage, the five-year survival rate of patients can be as high as 90%. However, the five-year survival rate drops significantly to only 10 to 15% at the advanced - metastatic stage. Early detection of the disease can no doubt save lives. Economically, it also costs much less to treat an early-diagnosed disease than advanced cancer”, said Dr. Jozef Dolinský.

The availability of COLOTECTTM 1.0 in Slovakia offers an easy and convenient alternative for accurate screening and detection. “Its sensitivity for detecting colorectal cancers is 88%, and specificity for identifying subjects without advanced colorectal neoplasm is 92%. Most importantly, for early detection, its sensitivity for advanced adenoma is 46%”, Dr. Lucia Starovecká Copák noted.

COLOTECTTM 1.0 is CE-marked, available in more than 20 countries across South-East Europe, including Slovakia, Hungary, Poland, Romania, North Macedonia, Slovenia, Portugal, and many more.

Fecal samples of COLOTECTTM 1.0 can be self-collected in the privacy of your own home at any time. The ease of use and non-invasive nature of the test is expected to help overcome many of the obstacles to colorectal cancer screening faced by patients.

For more information on its availability in Slovakia, please visit www.colotect.sk. For its availability in other countries, please get in touch with BGI Genomics at info@bgi.com.

END


[Attachments] See images for this press release:
BGI Genomics partners with Zentya to launch fecal DNA test for colorectal cancer in Slovakia BGI Genomics partners with Zentya to launch fecal DNA test for colorectal cancer in Slovakia 2 BGI Genomics partners with Zentya to launch fecal DNA test for colorectal cancer in Slovakia 3

ELSE PRESS RELEASES FROM THIS DATE:

Fake news on Facebook increased 2020 election doubts

2023-03-30
PULLMAN, Wash. — Facebook users were more likely to read fake news about the 2020 U.S. presidential election than users of Twitter and other social media websites, a Washington State University-led analysis found.  The study in Government Information Quarterly indicates that fake news consumption and political alignment were the primary forces driving doubt about the integrity of the vote counting process – and surprisingly not the method used to cast votes. The researchers also found that individuals who got ...

SLAS discovery highlights protocols in drug discovery for March special issue

SLAS discovery highlights protocols in drug discovery for March special issue
2023-03-30
Oak Brook, IL – The March special issue of SLAS Discovery deviates from its traditional focus on assay technology, disease area or molecular target to introduce and explore protocol articles – the newly accepted article type for outlining detailed scientific methods and procedures. The six protocol articles featured in this month’s collection cover a range of topics such as 3D imaging, cancer treatments and methods of high-throughput screening. By publishing protocols, SLAS underscores the importance of transparency and rigor ...

Machine learning models rank predictive risks for Alzheimer’s disease

2023-03-30
COLUMBUS, Ohio – Once adults reach age 65, the threshold age for the onset of Alzheimer’s disease, the extent of their genetic risk may outweigh age as a predictor of whether they will develop the fatal brain disorder, a new study suggests. The study, published recently in the journal Scientific Reports, is the first to construct machine learning models with genetic risk scores, non-genetic information and electronic health record data from nearly half a million individuals to rank risk factors in order of how strong their association is with eventual development of ...

Cognitive neuroscientist Biyu J. He receives Vilcek Prize for Creative Promise in Biomedical Science

Cognitive neuroscientist Biyu J. He receives Vilcek Prize for Creative Promise in Biomedical Science
2023-03-30
Biyu J. He receives the Vilcek Prize for Creative Promise in Biomedical Science for her leadership in the field of cognitive neuroscience, and for her groundbreaking discoveries on the biological bases of perceptual cognition and subjective experience. The Vilcek Prize for Creative Promise is a $50,000 prize awarded annually by the Vilcek Foundation as part of its prizes program. Awarded annually since 2006, the Vilcek Foundation prizes recognize and celebrate immigrant contributions to scientific research and ...

Prestigious EU support to save species

Prestigious EU support to save species
2023-03-30
The European Research Council (ERC) has awarded a prestigious Advanced Grant of EUR 2.5 million ($2.6 million) over 5 years to Professor Bernt-Erik Sæther at the Norwegian University of Science and Technology's (NTNU) Department of Biology. The money will go to find out how we can save species that are in danger of becoming extinct. “The aim is to develop rules of thumb to identify what is needed to prevent a species from dying out in an area in the short term. At the same time, we must ensure that a population’s ability to adapt to ...

Children with high blood pressure often become adults with high blood pressure

2023-03-30
Statement Highlights: Primary hypertension—high blood pressure that is not due to an underlying medical condition—occurs in up to 5% of children and adolescents in the U.S. and other countries. Having high blood pressure as a child often leads to high blood pressure in adulthood, which may increase the likelihood of heart disease and stroke, as well as cause damage to the kidneys, eyes and more. Some risk factors that increase the chances for high blood pressure in children are modifiable, while others are not. Regular and appropriate assessment of blood pressure levels in children is important, as there are often no symptoms of high blood pressure. Public health initiatives ...

Cacao lovers rejoice: Cacao of Excellence R&D Laboratory and Training Centre unveiled

Cacao lovers rejoice: Cacao of Excellence R&D Laboratory and Training Centre unveiled
2023-03-30
ROME, ITALY - Cacao of Excellence is proud to unveil its new state-of-the-art cacao R&D laboratory and training centre. Located at Via Baccio Baldini 4 in Rome, the facility will be dedicated to exploring the depths of cacao quality and sensory analysis and revealing the diversity of cacao flavour profiles. The laboratory and training centre will accommodate the processing and evaluation of cacao samples received from over 55 participating origins for the global Cacao of Excellence Awards, and will serve as a cacao quality processing and sensory training centre for cacao-producing origins. Cacao of Excellence’s ...

A bright spot in the treatment of lateral disc meniscus injuries in for youth

A bright spot in the treatment of lateral disc meniscus injuries in for youth
2023-03-30
Osaka, Japan― Tearing their meniscus—a crescent-shaped piece of a soft cushion of cartilage located between the femur and tibia—can be devastating for young athletes. It is easily damaged in people with congenital lateral discoid meniscus or those that are physically active and once damaged, the meniscus cannot repair itself. The most common method has been to remove the damaged portion of the meniscus, but in recent years meniscus-sparing surgeries, that suture the margins of the meniscus at the tear, ...

Springer Nature and EMBO cooperate to publish the EMBO Press suite of journals

Springer Nature and EMBO cooperate to publish the EMBO Press suite of journals
2023-03-30
30 March 2023 - EMBO Press has chosen Springer Nature to be their new publishing partner from 1 January 2024. Authors who publish in EMBO Press journals will benefit from the global reach of Springer Nature’s leading journals. In addition, authors will have the option to transfer manuscripts between journals in the EMBO Press and Springer Nature portfolios.  This announcement follows EMBO Press’ recent decision that to advance global discoverability, transparency and availability of published research outcomes all ...

Funding awarded to accelerate battery research, supporting ambitions of a cleaner, greener future

2023-03-30
Birmingham researchers developing novel battery recycling techniques have been awarded funding by the Faraday Institution, as part of a £29m package to re-focus and accelerate key battery research projects, which have been reshaped to focus on areas with the greatest potential for success. Four of the six projects funded involve the University of Birmingham, and these include the Reuse and Recycling of Lithium Ion Batteries (ReLIB) project.  Led by Professor Paul Anderson, Co-Director of the Birmingham Centre for Strategic Elements and Critical Materials at Birmingham’s School of Chemistry, ReLIB aims to develop and scale novel recycling technologies that recover valuable ...

LAST 30 PRESS RELEASES:

Cryptographic protocol enables secure data sharing in the floating wind energy sector

Can drinking coffee or tea help prevent head and neck cancer?

Development of a global innovative drug in eye drop form for treating dry age-related macular degeneration

Scientists unlock secrets behind flowering of the king of fruits

Texas A&M researchers illuminate the mysteries of icy ocean worlds

Prosthetic material could help reduce infections from intravenous catheters

Can the heart heal itself? New study says it can

Microscopic discovery in cancer cells could have a big impact

Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer

Breakthrough new material brings affordable, sustainable future within grasp

How everyday activities inside your home can generate energy

Inequality weakens local governance and public satisfaction, study finds

Uncovering key molecular factors behind malaria’s deadliest strain

UC Davis researchers help decode the cause of aggressive breast cancer in women of color

Researchers discovered replication hubs for human norovirus

SNU researchers develop the world’s most sensitive flexible strain sensor

Tiny, wireless antennas use light to monitor cellular communication

Neutrality has played a pivotal, but under-examined, role in international relations, new research shows

Study reveals right whales live 130 years — or more

Researchers reveal how human eyelashes promote water drainage

Pollinators most vulnerable to rising global temperatures are flies, study shows

DFG to fund eight new research units

Modern AI systems have achieved Turing's vision, but not exactly how he hoped

Quantum walk computing unlocks new potential in quantum science and technology

Construction materials and household items are a part of a long-term carbon sink called the “technosphere”

First demonstration of quantum teleportation over busy Internet cables

Disparities and gaps in breast cancer screening for women ages 40 to 49

US tobacco 21 policies and potential mortality reductions by state

AI-driven approach reveals hidden hazards of chemical mixtures in rivers

Older age linked to increased complications after breast reconstruction

[Press-News.org] BGI Genomics partners with Zentya to launch fecal DNA test for colorectal cancer in Slovakia
BGI Genomics is pleased to announce the launch of COLOTECT™ 1.0 in Slovakia, in collaboration with its local partner, Zentya